Home | Sitemap | Imprint
 
Search:
 
 
   
DGRA INTRANET
 
   
Internal information for members.
Name:
Password:
Forgotten your password?
   
BUSINESS OFFICE:
 
   
Adenauerallee 15
D-53111 Bonn,
Germany

Phone: +49 (0)228 368264-6
Fax: +49 (0)228 368264-7
E-Mail: info@dgra.de
 
DRUG REGULATORY AFFAIRS COURSE
Module 8: Chemical-pharmaceutical documentation

Method of examination: Course work and written or oral examination
Credit points: 6

Module Head: Dr. Susanne Keitel

No  

Topics

     
1  

Formal requirements:

  • Notice to Applicants vs. Common Technical Document (Quality)
  • Quality-relevant information for the SPC and Patient Information Leaflet/Physicians’ Circular

Special characteristics of the analytical expert report and the quality overall summary 

     
2  

Production of starting materials

  • Requirements for new and know substances
  • Pharmacopoeial monographs
  • EDMF vs. certificate of suitability
  • Impurities and degradation products
  • Batch conformity 
     
3  

Validation of analytic methods

  • Development of internal company test methods
  • Product-specific validation of pharmacopoeial methods
  • Cross-validation
  • Method transfer 
     
4  

Composition, development and production

  • Product development in general and responsibilities of pharmaceutical development (preformulation, formulation development, investigations into the suitability of the container material)
  • Production formula / production methods / production regulations
  • Process validation
  • Requirements for special dosage forms 
     
5  

Primary packaging – requirements for development and routine testing

     
6  

Biopharmacology

     
7  

Specifications of starting substances and finished pharmaceutical products

  • Establishment of specifications
  • Reference substances
  • Changes to specifications during development and after marketing authorization
  • Batch testing
  • Certificates of analysis
   
8  

Stability/shelf life (Part II F.)

  • Stability testing of the active substance
  • Stability testing of the finished product
  • Release vs shelf-life specification
  • Test plan and evaluation
  • Abridged stability testing (extrapolation, bracketing, matrixing)
     
9  

Special requirments for biotechnology-derived substances and pharmaceuticals

  • Production of active substances · Specification determination /impurities
  • In-process controls
  • Documents on Common Technical Document (CTD) Appendix 2
  • Stability testing
  • Comparability 
     
10  

Common deficiencies of regulatory dossiers

     
11   Preparation of a model dossier (group work)

 
« back
 
page up print
 
Studiengang (M.D.R.A.)
Abschluß: Master of Drug
Regulatory Affairs
mehr Informationen »
DGRA-Fortbildungen:
DGRA Workshops:

28. - 29. August 2012
Update Workshop

27. November 2012
Therapeutische Vaccine

Jahreskongresse:

30. - 31. Mai 2012
DGRA-Jahreskongress 2012

mehr Fortbildungen »
Job-Börse:
Angebot vom 20.04.2012
Naturwissenschaftler/in der Fachrichtungen Pharmazie, Chemie, Lebensmittelchemie oder Biologie für Bereich Regulatory Affairs

Angebot vom 21.03.2012
Regulatory Affairs Manager (m/w)

mehr Stellenangebote »
© 2011, DGRA e.V.
Letzte Aktualisierung am:
Samstag, 28.08.2010